Stem cell therapy displays promise for people battling heart failing, a new study finds. The clinical trial found that end-stage heart failure patients treated with control cells harvested from their own bone fragments marrow had 37 percent less cardiac events than those who obtained a “dummy” placebo. “For the final 15 years, everyone has been…